WC
AMGN icon

Wexford Capital’s Amgen AMGN Stock Holding History

Wexford Capital’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-10,776
Closed -$2.01M – 120
2017
Q3 		$2.01M Buy
10,776
+8,676
+413% +$1.54M 0.17% 60
2017
Q2 		$362K Buy
+2,100
New +$342K 0.03% 129
2014
Q1 		– Sell
-75,394
Closed -$8.6M – 178
2013
Q4 		$8.6M Buy
75,394
+64,284
+579% +$7.31M 0.74% 13
2013
Q3 		$1.24M Buy
+11,110
New +$1.2M 0.1% 105

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wexford Capital's AMGN Position: Q4 2017 in Review

Wexford Capital sold out of Amgen (AMGN) in Q4 2017, closing a stake of 10,776 shares — an estimated $2.01M sold.

Wexford Capital first reported a position in AMGN in Q3 2013 and held it in 4 quarters. The position peaked at $8.6M in Q4 2013. 1,734 funds tracked by Wall St. Rank hold AMGN as of Q4 2017.

  • Wexford Capital reported no remaining Amgen position as of Q4 2017 after selling out during the quarter.
  • Wexford Capital sold 10,776 Amgen shares in Q4 2017, an estimated $2.01M.
  • Wexford Capital first reported a position in Amgen in Q3 2013 and held it in 4 quarters.
  • Wexford Capital's Amgen position peaked at $8.6M in Q4 2013.
  • 1,734 funds tracked by Wall St. Rank held Amgen as of Q4 2017.

Based on Wexford Capital's 13F filing for Q4 2017, filed 13 Feb 2018.